sb 203580 has been researched along with Cancer of Ovary in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, R; Si, L; Yang, R; Yang, S | 1 |
| Bazer, FW; Lim, W; Park, S; Song, G | 1 |
| Chen, H; Fu, Y; Han, X; Postovit, LM; Steed, H; Zhou, J | 1 |
| Alampi, DM; Carenini, N; Ciusani, E; Corna, E; Corno, C; Gatti, L | 1 |
| Ge, J; Huang, K; Qi, C; Wu, W; Xie, T; Xu, X; Xue, B; Yu, Y; Zhang, H | 1 |
| Chang, Z; Fan, Q; Wang, F; Wang, L | 1 |
| Guo, H; Ji, M; Peng, Z; Shi, H; Shi, M; Xie, Y | 1 |
| Kumar, S; Liou, JP; Pai, HC; Pan, SL; Shen, CC; Teng, CM | 1 |
| Chen, X; Huang, L; Huang, P; Lou, J; Pan, S; Sun, R; Wang, F; Wu, M; Zhang, S; Zhang, X | 1 |
| Deng, S; Hu, J; Lu, M; Xiao, L; Xu, Y | 1 |
| An, BS; Choi, JH; Choi, KC; Jeung, EB; Kim, KY; Leung, PC; Park, SH | 1 |
| Cong, Q; Jiang, W; Li, MJ; Wang, YS; Xu, CJ; Ye, B | 1 |
| Berger, S; Denkert, C; Hauptmann, S; Köbel, M; Koch, I; Siegert, A | 1 |
| Arimoto-Ishida, E; Hisamoto, K; Ikebuchi, Y; Kimura, A; Mabuchi, S; Murata, Y; Nishio, Y; Ohmichi, M; Takahashi, K; Tasaka, K | 1 |
| Auersperg, N; Choi, KC; Chou, CS; Kim, KY; Leung, PC; Park, SH | 1 |
| Bagnato, A; Di Castro, V; Elia, G; Natali, PG; Rosanò, L; Spinella, F | 1 |
| Bae, YS; Kim, JM; Kim, MK; Kim, SD; Lee, HY; Lee, SY; Park, KS; Ryu, SH | 1 |
| Lou, L; Quan, H; Xu, Y | 1 |
| Li, Z; Lu, M; Xiao, L | 1 |
| Bai, W; Jiang, F; Lee, H; Nicosia, SV; Su, B; Wang, Q; Yang, J | 1 |
20 other study(ies) available for sb 203580 and Cancer of Ovary
| Article | Year |
|---|---|
Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway.
Topics: Alkaloids; Anthracenes; Apoptosis; Benzodioxoles; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Proliferation; Cell Survival; Female; Humans; Imidazoles; MAP Kinase Kinase 4; Oligopeptides; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Piperidines; Polyunsaturated Alkamides; Pyridines; Tumor Suppressor Proteins | 2018 |
The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
Topics: Analysis of Variance; Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Synergism; Enzyme Inhibitors; Female; G1 Phase; Humans; Imidazoles; Isoflavones; MAP Kinase Signaling System; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Morpholines; Nitriles; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Reactive Oxygen Species; Resting Phase, Cell Cycle; Signal Transduction | 2018 |
Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Imidazoles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Tumor Cells, Cultured | 2018 |
AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells.
Topics: Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Cell Line, Tumor; Cisplatin; Drug Synergism; Female; Humans; Imidazoles; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyridines; Receptor Protein-Tyrosine Kinases; STAT3 Transcription Factor | 2019 |
Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
Topics: Antigens, Neoplasm; Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Chromones; Cyclams; Dose-Response Relationship, Drug; Extracellular Matrix; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Imidazoles; Integrins; Morpholines; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors; Urokinase-Type Plasminogen Activator | 2013 |
Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2.
Topics: Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Female; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Pyridines | 2014 |
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Imidazoles; Metformin; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines | 2014 |
MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Topics: Animals; Antineoplastic Agents; Aurora Kinase B; Benzyl Compounds; Carcinoma; Caspase 3; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin B; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Histones; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Mice; Molecular Chaperones; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pyridines; Signal Transduction; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2015 |
TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.
Topics: Adult; Aged; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Enzyme Inhibitors; Female; Humans; Imidazoles; MAP Kinase Signaling System; Middle Aged; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Tumor Microenvironment | 2016 |
Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Early Growth Response Protein 1; Female; Humans; Imidazoles; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; Signal Transduction | 2008 |
Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38.
Topics: Cell Growth Processes; Endocrine Disruptors; Enzyme Activation; Enzyme Inhibitors; Estrogens; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Estrogen; Response Elements; Signal Transduction; Tumor Cells, Cultured | 2009 |
[Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Topics: Blood Platelets; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Migration Assays; Cyclic AMP Response Element-Binding Protein; Female; Humans; Imidazoles; In Vitro Techniques; Matrix Metalloproteinase 2; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridines; Receptors, G-Protein-Coupled; Time Factors | 2011 |
Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Cytokines; Drug Combinations; Enzyme Induction; Enzyme Inhibitors; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Inflammation; Interleukin-1; Laminin; MAP Kinase Kinase 1; MAP Kinase Signaling System; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Proteins; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteoglycans; Pyridines; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2003 |
Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antioxidants; Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Flavonoids; G1 Phase; Gene Expression; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Estrogen; Tamoxifen | 2004 |
Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.
Topics: Adenocarcinoma; Apoptosis; Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Female; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Transcription Factor AP-1 | 2004 |
Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Induction; ErbB Receptors; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Protein Kinase Inhibitors; Pyridines; Quinazolines; Receptor, Endothelin A; Signal Transduction; Transcriptional Activation; Tyrphostins | 2004 |
S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells.
Topics: Blotting, Western; Calcium; Cell Line, Tumor; Cell Movement; Chemotaxis; Chromones; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lysophospholipids; Morpholines; Neoplasm Invasiveness; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphoinositide-3 Kinase Inhibitors; Protein Isoforms; Proto-Oncogene Proteins c-akt; Pyridines; Receptors, Lysosphingolipid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sphingosine | 2007 |
p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Humans; Imidazoles; Liver Neoplasms; Male; Microtubules; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; Stilbenes; Time Factors | 2008 |
The relationship between p38MAPK and apoptosis during paclitaxel resistance of ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Imidazoles; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Pyridines; RNA, Messenger; Transfection; Tumor Suppressor Protein p53 | 2007 |
MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
Topics: Endometrial Neoplasms; Enzyme Activation; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor alpha; Female; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 2; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Pyridines; Receptors, Estrogen; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured | 2000 |